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220* IP-10 induction after LPS stimulation is compromised in cystic
ﬁbrosis bronchial epithelial cells
M.O. Henke1, D.C. Gruenert3, B.K. Rubin2, G. John1. 1Philipps-University,
Marburg, Germany; 2Wake Forest University, Winston-Salem, NC, USA;
3California Paciﬁc Medical Center, San Francisco, CA, USA
As part of the innate immune system, airway epithelial cells secrete proinﬂammatory
cytokines after activation of Toll-like receptors (TLR) by pathogens. We have shown
that in CF bronchial epithelial cells, a reduced surface expression of TLR-4 causes
a diminished IL-8 response to LPS. However, there is no information regarding
activation of the MyD88 independent TLR-4 signaling pathway by LPS which
results in the secretion of the T-cell recruiting chemokine IFN-g-inducible protein
(IP)-10. Therefore, we investigated the induction IP-10 in CF bronchial epithelial
cell line CFBE41o- and its CFTR corrected isotype.
CF cell line CFBE41o- (CFTR mutation DF508/DF508) and its CFTR corrected
isotype (wild-type CFTR plasmid transfectant) were cultivated under air-liquid
interface conditions. TLR-4 surface expression was revealed by FACS analysis.
Basal and LPS stimulated IP-10 secretions were analyzed by ELISA.
TLR-4 surface expression was signiﬁcantly reduced in CFBE41o- by a factor of
2, compared to the CFTR-corrected cells. CF cells exhibited higher baseline IP-
10 secretions compared to the CFTR-corrected cells, but showed no response to
LPS. In CFTR-corrected cells, stimulation with LPS increased IP-10 secretions by
a factor of 3. Incubating cells with siRNA directed against TLR-4 inhibited the LPS
stimulated increase of IP-10 in CFTR-corrected cells. In all experiments, CFBE41o-
cells transfected with a control plasmid showed results similar to those observed
for the CFBE41o- cells.
The reduced TLR-4 surface expression in CF cells causes the loss of induction of
IP-10 by LPS. This could compromise adaptive immune responses in CF due to a
reduced T-cell recruitment.
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221* Drug speciﬁc T cells in patients with a history of non-immediate
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Intravenous antibiotics are essential to treat pulmonary exacerbations in cystic
ﬁbrosis (CF). Up to 5% of treatment courses are complicated by hypersensitiv-
ity reactions, most commonly to beta-lactam antibiotics. They are usually non-
immediate and an accelerated response is seen following re-exposure in keeping
with an immunological process. Symptoms usually consist of maculopapular rashes,
fevers, and arthralgia. The aetiology of these reactions has never been established.
25 CF patients with previous non-immediate reactions to intravenous antibiotics
have been assessed to date. These patients were skin prick test negative to the
causative antibiotics and had no history suggestive of an IgE mediated reaction.
8 non-allergic CF patients were used as tolerant controls together with 5 non-CF
naive controls.
The lymphocyte transformation test (LTT) identiﬁes drug speciﬁc T cells in-vitro.
During the LTT patient’s lymphocytes are cultured with the antibiotic, if drug
speciﬁc T cells are present proliferative responses are seen. Responses 3 times
greater than the negative control readings are considered positive.
Reliable positive responses have been identiﬁed in patients with reactions to
piperacillin (12/16, 75%), co-trimoxazole (5/9, 56%), and colomycin (6/14, 43%).
Importantly, no proliferative responses were seen in the tolerant patients.
It is likely that the non-immediate reactions seen frequently in CF originate from
drug speciﬁc T cells. Investigations to clone and type these cells, together with
evaluating their cytokine proﬁles, have been commenced.
222* Cytokine production in the differentiating human airway
epithelium
S. Crespin1, T. Dudez1, I. Scerri1, M. Chanson1. 1Geneva University Hospitals
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A pro-inﬂammatory state of the human airway epithelium has been proposed to
explain the exaggerated recruitment of neutrophils to the airways of patients with
cystic ﬁbrosis (CF). We developed a model of primary Human Airway Epithelial
Cell (HAEC) culture isolated from nasal polyps. HAEC could be ampliﬁed up
to 3 passages, and for each passage differentiated at the air-liquid interface into
a mucociliated pseudostratiﬁed epithelium within 30 days. The production of
IL-8, which is highly elevated in CF HAEC cultures, decreased with time of
differentiation, as shown by ELISA. We next studied the release of IL-8 and of
IL-6 induced by TNF-alpha in 30 days HAEC cultures and as a function of cell
passage. Although CF HAEC showed enhanced basal and stimulated release of
IL-8 and IL-6 at early passage, this difference vanished for higher cell passages.
Finally, the production of 79 cytokines was analyzed by a cytokine array in 7-
and 30-days old cultures generated from passage 2 HAEC. Seven days CF HAEC
cultures showed increased production of GM-CSF, GRO-alpha, IL-5, IL-6, IL-7 and
MCP-1 but decreased production of TIMP-1 as compared to non-CF cultures. This
difference in cytokine production, with the exception of IL-6, disappeared in 30 days
HAEC cultures. Thus, our results revealed a huge difference in cytokine production
in non-differentiated CF HAEC as compared to non-CF cells; this difference was
abolished in well differentiated and polarized HAEC. They also indicate that there is
no intrinsic CFTR-dependent anomaly of cytokine secretion by CF HAEC. This data
may reconcile opposite reports based on different models of culture and address the
question of the role playing by proliferation factors on the innate immune response
in CF.
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Early in life, CF patients become infected with microorganisms including bacteria,
particularly Pseudomonas aeruginosa, and fungi, Aspergillus fumigatus. Recent
research has identiﬁed anti-inﬂammatory properties of statins beside their lipid-
lowering effect. Therefore, we have investigated the effect of ﬂuvastatin on IL-8 se-
cretion, using ELISA, and gene expression, using quantitative PCR. Human primary
macrophages were obtained by differentiation of peripheral blood mononuclear cells
with GM-CSF. Besides whole blood from adult CF patients were collected at the
Rennes Teaching Hospital (France) accordingly to the local ethical committee.
Whole blood or macrophages were pretreated 1 h by ﬂuvastatin and incubated
24 h with lipopolysaccharide from Pseudomonas aeruginosa and/or Aspergillus
fumigatus antigens. In both cultures, IL-8 protein levels were dose-dependently
increased when cells were stimulated by Aspergillus antigens or lipopolysaccharide.
Additive effects were observed in case of co-stimulation. We also demonstrate that
ﬂuvastatin strongly decreases protein levels of IL-8 in a concentration-dependent
manner. Similarly, in macrophages, ﬂuvastatin induced potent down-regulation of
IL-8 mRNA levels.
In conclusion the inhibitory effects of ﬂuvastatin on systemic and local inﬂammation
could reveal important therapeutic potential of statins in various pathological
conditions associated with over-production of pro-inﬂammatory cytokines and
chemokines like observed in cystic ﬁbrosis.
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